Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Skinner

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The European Respiratory Journal|August 15, 2024
Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbationsDavid M G Halpin, Heath Healey, Derek Skinner, et al.
Eclinicalmedicine|November 12, 2019
Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019David M G Halpin, Hilda J I de Jong, Victoria Carter, et al.
Pragmatic and Observational Research|October 3, 2019
Management Of Community-Acquired Pneumonia: An Observational Study In UK Primary CareNaomi Launders, Dermot Ryan, Christopher C Winchester, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 2, 2017
The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database studyRupert Jones, Jessica Martin, Vicky Thomas, et al.
Heart (British Cardiac Society)|July 7, 2016
Underuse of β-blockers in heart failure and chronic obstructive pulmonary diseaseBrian Lipworth, Derek Skinner, Graham Devereux, et al.
Heart (British Cardiac Society)|November 13, 2016
It is important to distinguish between HFrEF and HFpEF when interpreting these dataBrian Lipworth, Derek Skinner, Graham Devereux, et al.
Advances in Therapy|April 8, 2025
The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and ObesityAlan Kaplan, Heath Heatley, John Townend, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 30, 2024
Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication SuccessHana Müllerová, Jeffrey Shi Kai Chan, Heath Heatley, et al.
NPJ Primary Care Respiratory Medicine|October 14, 2016
Inappropriate asthma therapy-a tale of two countries: a parallel population-based cohort studyManon Belhassen, Anjan Nibber, Eric Van Ganse, et al.
Advances in Therapy|November 19, 2024
Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPDGary Tse, Cono Ariti, Mona Bafadhel, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The European Respiratory Journal|August 15, 2024
Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbationsDavid M G Halpin, Heath Healey, Derek Skinner, et al.
Eclinicalmedicine|November 12, 2019
Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019David M G Halpin, Hilda J I de Jong, Victoria Carter, et al.
Pragmatic and Observational Research|October 3, 2019
Management Of Community-Acquired Pneumonia: An Observational Study In UK Primary CareNaomi Launders, Dermot Ryan, Christopher C Winchester, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 2, 2017
The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database studyRupert Jones, Jessica Martin, Vicky Thomas, et al.
Heart (British Cardiac Society)|July 7, 2016
Underuse of β-blockers in heart failure and chronic obstructive pulmonary diseaseBrian Lipworth, Derek Skinner, Graham Devereux, et al.
Heart (British Cardiac Society)|November 13, 2016
It is important to distinguish between HFrEF and HFpEF when interpreting these dataBrian Lipworth, Derek Skinner, Graham Devereux, et al.
Advances in Therapy|April 8, 2025
The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and ObesityAlan Kaplan, Heath Heatley, John Townend, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 30, 2024
Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication SuccessHana Müllerová, Jeffrey Shi Kai Chan, Heath Heatley, et al.
NPJ Primary Care Respiratory Medicine|October 14, 2016
Inappropriate asthma therapy-a tale of two countries: a parallel population-based cohort studyManon Belhassen, Anjan Nibber, Eric Van Ganse, et al.
Advances in Therapy|November 19, 2024
Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPDGary Tse, Cono Ariti, Mona Bafadhel, et al.
Pageof 3